| Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism GJ Peters, HHJ Backus, S Freemantle, B Van Triest, G Codacci-Pisanelli, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1587 (2-3 …, 2002 | 488 | 2002 |
| Epigenetic treatment of solid tumours: a review of clinical trials C Nervi, E De Marinis, G Codacci-Pisanelli Clinical epigenetics 7, 1-20, 2015 | 216 | 2015 |
| Thymidylate synthase and drug resistance GJ Peters, CL Van der Wilt, B Van Triest, G Codacci-Pisanelli, ... European Journal of Cancer 31 (7-8), 1299-1305, 1995 | 202 | 1995 |
| Chemotherapy, targeted agents, antiemetics and growth-factors in human milk: how should we counsel cancer patients about breastfeeding? B Pistilli, G Bellettini, E Giovannetti, G Codacci-Pisanelli, HA Azim Jr, ... Cancer treatment reviews 39 (3), 207-211, 2013 | 69 | 2013 |
| Intravesical administration of gemcitabine in superficial bladder cancer: a phase I study with pharmacodynamic evaluation E De Berardinis, G Antonini, GJ Peters, WJP Loves, K Van der Born, ... BJU international 93 (4), 491-494, 2004 | 62 | 2004 |
| Mechanisms of chemotherapy-induced ovarian damage in breast cancer patients G Codacci-Pisanelli, L Del Pup, M Del Grande, FA Peccatori Critical reviews in oncology/hematology 113, 90-96, 2017 | 58 | 2017 |
| Breast cancer risk of hormonal contraception: Counselling considering new evidence L Del Pup, G Codacci-Pisanelli, F Peccatori Critical reviews in oncology/hematology 137, 123-130, 2019 | 54 | 2019 |
| Biology, staging, and treatment of breast cancer during pregnancy: reassessing the evidences FA Peccatori, M Lambertini, G Scarfone, L Del Pup, G Codacci-Pisanelli Cancer Biology & Medicine 15 (1), 6, 2018 | 49 | 2018 |
| Whole body MRI for systemic staging of breast cancer in pregnant women FA Peccatori, G Codacci-Pisanelli, M Del Grande, G Scarfone, F Zugni, ... The breast 35, 177-181, 2017 | 49 | 2017 |
| Attitudes on fertility issues in breast cancer patients: an Italian survey N Biglia, R Torrisi, M D’Alonzo, G Codacci Pisanelli, S Rota, FA Peccatori Gynecological Endocrinology 31 (6), 458-464, 2015 | 45 | 2015 |
| Risk of cancer after assisted reproduction: a review of the available evidences and guidance to fertility counselors L Del Pup, FA Peccatori, PE Levi-Setti, G Codacci-Pisanelli, P Patrizio European Review for Medical and Pharmacological Sciences 22 (22), 8042-8059, 2018 | 40 | 2018 |
| Quantitative real time PCR of deoxycytidine kinase mRNA by Light Cycler PCR in relation to enzyme activity and gemcitabine sensitivity J Sigmond, JR Kroep, W Loves, G Codacci-Pisanelli, GJ Peters Cancer letters 213 (2), 173-179, 2004 | 34 | 2004 |
| Antitumour activity, toxicity and inhibition of thymidylate synthase of prolonged administration of 5-fluorouracil in mice G Codacci-Pisanelli, CL Van der Wilt, HM Pinedo, F Franchi, P Noordhuis, ... European Journal of Cancer 31 (9), 1517-1525, 1995 | 33 | 1995 |
| Modulation of 5-fluorouracil in mice using uridine diphosphoglucose. G Codacci-Pisanelli, J Kralovanszky, CL Van der Wilt, P Noordhuis, ... Clinical cancer research: an official journal of the American Association …, 1997 | 27 | 1997 |
| Chemotherapy and target therapy in the management of adult high-grade gliomas G Paolo Spinelli, E Miele, G Lo Russo, M Miscusi, G Codacci-Pisanelli, ... Current cancer drug targets 12 (8), 1016-1031, 2012 | 24 | 2012 |
| Pregnancy and lactation: risk or protective factors for breast cancer? B Migliavacca Zucchetti, FA Peccatori, G Codacci-Pisanelli Diseases of the Breast during Pregnancy and Lactation, 195-197, 2020 | 21 | 2020 |
| Intrarticular methotrexate in the therapy of rheumatoid arthritis. F Franchi, P Seminara, G Codacci-Pisanelli, T Aronne, A Avella, ... Recenti Progressi in Medicina 80 (5), 261-262, 1989 | 21 | 1989 |
| Medical treatment of early stage and rare histological variants of epithelial ovarian cancer NT Cont, A Ferrero, FA Peccatori, M D’Alonzo, G Codacci-Pisanelli, ... ecancermedicalscience 9, 2015 | 19 | 2015 |
| Intermittent continuous infusion of 5-fluorouracil and low dose oral leucovorin in patients with gastrointestinal cancer: relationship between plasma concentrations and … RL Poorter, GJ Peters, PJM Bakker, CW Taat, DMJ Biermans-van Lecuwe, ... European Journal of Cancer 31 (9), 1465-1470, 1995 | 19 | 1995 |
| Bringing onco-innovation to Europe’s healthcare systems: The potential of biomarker testing, real world evidence, tumour agnostic therapies to empower personalised medicine D Horgan, G Ciliberto, P Conte, G Curigliano, L Seijo, LM Montuenga, ... Cancers 13 (3), 583, 2021 | 17 | 2021 |
